Skip to main content
Top
Published in: Archives of Virology 11/2008

01-11-2008 | Brief Report

Adeno-associated virus type 2 vectors: transduction and long-term expression in cerebellar Purkinje cells in vivo is mediated by the fibroblast growth factor receptor 1

bFGFR-1 mediates AAV2 transduction of Purkinje cells

Authors: Lalitha R. Belur, William F. Kaemmerer, R. Scott McIvor, Walter C. Low

Published in: Archives of Virology | Issue 11/2008

Login to get access

Abstract

The receptor for adeno-associated virus serotype 2 (AAV2) in Purkinje cells has not been identified, but based on work carried out in non-neuronal cell lines, heparan sulfate proteoglycan is thought to act as a primary receptor, with basic fibroblast growth factor receptor-1 being reported as a co-receptor. In this study, using antibody interference and protein competition strategies, we show specific reduction in Purkinje cell transduction by AAV2 vector in the presence of these inhibitors. We also demonstrate AAV2-mediated transgene expression in Purkinje cells in vivo that extends out to one year post-injection. These results provide new information on fibroblast growth factor receptor-1 involvement in AAV2-mediated transduction of Purkinje cells and have important implications for AAV-mediated treatment of various cerebellar disorders.
Literature
1.
go back to reference Choi VW, McCarty DM, Samulski RJ (2005) AAV hybrid serotypes: improved vectors for gene delivery. Curr Gene Ther 5:299–310PubMedCrossRef Choi VW, McCarty DM, Samulski RJ (2005) AAV hybrid serotypes: improved vectors for gene delivery. Curr Gene Ther 5:299–310PubMedCrossRef
2.
go back to reference Burger C, Gorbayatuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S, Reier PJ, Mandel RJ, Muzyczka N (2004) Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 10:302–317PubMedCrossRef Burger C, Gorbayatuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S, Reier PJ, Mandel RJ, Muzyczka N (2004) Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 10:302–317PubMedCrossRef
3.
go back to reference Taymans JM, Vandenberghe LH, Haute CV, Thiry I, Deroose CM, Mortelmans L, Wilson JM, Debyser Z, Baekelandt V (2007) Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. Hum Gene Ther 18:195–220PubMedCrossRef Taymans JM, Vandenberghe LH, Haute CV, Thiry I, Deroose CM, Mortelmans L, Wilson JM, Debyser Z, Baekelandt V (2007) Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. Hum Gene Ther 18:195–220PubMedCrossRef
4.
go back to reference During MJ, Samulski RJ, Elsworth JD, Kaplitt MG, Leone P, Xiao X, Li J, Freese A, Taylor JR, Roth RH, Sladek JR, O’Malley KL, Redmond DE Jr (1998) In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Ther 5:820–827PubMedCrossRef During MJ, Samulski RJ, Elsworth JD, Kaplitt MG, Leone P, Xiao X, Li J, Freese A, Taylor JR, Roth RH, Sladek JR, O’Malley KL, Redmond DE Jr (1998) In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Ther 5:820–827PubMedCrossRef
5.
go back to reference Farkas SL, Zadori Z, Benko M, Essbauer S, Harrach B, Tijssen P (2004) A parvovirus isolated from royal python (Python regius) is a member of the genus Dependovirus. J Gen Virol 85:555–561PubMedCrossRef Farkas SL, Zadori Z, Benko M, Essbauer S, Harrach B, Tijssen P (2004) A parvovirus isolated from royal python (Python regius) is a member of the genus Dependovirus. J Gen Virol 85:555–561PubMedCrossRef
6.
go back to reference Flotte TR (2001) Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy. Curr Opin Mol Ther 3:497–502PubMed Flotte TR (2001) Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy. Curr Opin Mol Ther 3:497–502PubMed
7.
go back to reference McCowan TJ, Xiao X, Li J, Breese GR, Samulski RJ (1996) Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res 713:99–107CrossRef McCowan TJ, Xiao X, Li J, Breese GR, Samulski RJ (1996) Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res 713:99–107CrossRef
8.
go back to reference Klein RL, Meyer EM, Peel AL, Zolotukhin S, Meyers C, Muzyczka N, King MA (1998) Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors. Exp Neurol 150:183–194PubMedCrossRef Klein RL, Meyer EM, Peel AL, Zolotukhin S, Meyers C, Muzyczka N, King MA (1998) Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors. Exp Neurol 150:183–194PubMedCrossRef
9.
go back to reference Summerford C, Samulski RJ (1998) Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 72:1438–1445PubMed Summerford C, Samulski RJ (1998) Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 72:1438–1445PubMed
10.
go back to reference Qing K, Maf C, Hansen J, Zhou S, Dwarki V, Srivastava A (1999) Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med 5:71–77PubMedCrossRef Qing K, Maf C, Hansen J, Zhou S, Dwarki V, Srivastava A (1999) Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med 5:71–77PubMedCrossRef
11.
go back to reference Summerford C, Bartlett JS, Samulski RJ (1999) AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med 5:78–82PubMedCrossRef Summerford C, Bartlett JS, Samulski RJ (1999) AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med 5:78–82PubMedCrossRef
12.
go back to reference Kashiwakura Y, Tamayose K, Iwabuchi K, Hirai Y, Shimada T, Matsumoto K, Nakamura T, Watanabe M, Oshimi K, Daida H (2005) Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection. J Virol 79:609–614PubMedCrossRef Kashiwakura Y, Tamayose K, Iwabuchi K, Hirai Y, Shimada T, Matsumoto K, Nakamura T, Watanabe M, Oshimi K, Daida H (2005) Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection. J Virol 79:609–614PubMedCrossRef
13.
go back to reference Mizukami H, Young NS, Brown KE (1996) Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein. Virol 217:124–130CrossRef Mizukami H, Young NS, Brown KE (1996) Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein. Virol 217:124–130CrossRef
14.
go back to reference Kaemmerer WF, Reddy RG, Warlick CA, Hartung SD, McIvor RS, Low WC (2000) In vivo transduction of cerebellar Purkinje cells using adeno-associated virus vectors. Mol Ther 2:446–457PubMedCrossRef Kaemmerer WF, Reddy RG, Warlick CA, Hartung SD, McIvor RS, Low WC (2000) In vivo transduction of cerebellar Purkinje cells using adeno-associated virus vectors. Mol Ther 2:446–457PubMedCrossRef
15.
go back to reference Soussi-Yanicostas N, Hardelin JP, Arroyo-Jimenez MM, Ardouin O, Legouis R, Levilliers J, Traincard F, Betton JM, Cabanié L, Petit C (1996) Initial characterization of anosmin-1, a putative extracellular matrix protein synthesized by definite neuronal cell populations in the central nervous system. J Cell Sci 109:1749–1757PubMed Soussi-Yanicostas N, Hardelin JP, Arroyo-Jimenez MM, Ardouin O, Legouis R, Levilliers J, Traincard F, Betton JM, Cabanié L, Petit C (1996) Initial characterization of anosmin-1, a putative extracellular matrix protein synthesized by definite neuronal cell populations in the central nervous system. J Cell Sci 109:1749–1757PubMed
16.
go back to reference Matsuda S, Okumura N, Yoshimura H, Koyama Y, Sakanaka M (1992) Basic fibroblast growth factor-like immunoreactivity in Purkinje cells of the rat cerebellum. Neurosci 50:99–106CrossRef Matsuda S, Okumura N, Yoshimura H, Koyama Y, Sakanaka M (1992) Basic fibroblast growth factor-like immunoreactivity in Purkinje cells of the rat cerebellum. Neurosci 50:99–106CrossRef
17.
go back to reference Pinkstaff JK, Detterich J, Lynch G, Gall C (1999) Integrin subunit gene expression is regionally differentiated in adult brain. J Neurosci 19:1541–1546PubMed Pinkstaff JK, Detterich J, Lynch G, Gall C (1999) Integrin subunit gene expression is regionally differentiated in adult brain. J Neurosci 19:1541–1546PubMed
18.
go back to reference Fuxe K, Tinner B, Zoli M, Pettersson RF, Baird A, Biagini G, Chadi G, Agnati LF (1996) Computer-assisted mapping of basic fibroblast growth factor immunoreactive nerve cell populations in the rat brain. J Chem Neuroanat 11:13–35PubMedCrossRef Fuxe K, Tinner B, Zoli M, Pettersson RF, Baird A, Biagini G, Chadi G, Agnati LF (1996) Computer-assisted mapping of basic fibroblast growth factor immunoreactive nerve cell populations in the rat brain. J Chem Neuroanat 11:13–35PubMedCrossRef
Metadata
Title
Adeno-associated virus type 2 vectors: transduction and long-term expression in cerebellar Purkinje cells in vivo is mediated by the fibroblast growth factor receptor 1
bFGFR-1 mediates AAV2 transduction of Purkinje cells
Authors
Lalitha R. Belur
William F. Kaemmerer
R. Scott McIvor
Walter C. Low
Publication date
01-11-2008
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 11/2008
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-008-0222-7

Other articles of this Issue 11/2008

Archives of Virology 11/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine